Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cellceutix CTIX

Healthcare Biotechnology
Innovation Pharmaceuticals Inc is a clinical-stage pharmaceutical company in the United States. It is engaged in developing therapies with oncology, dermatology, and antimicrobial applications. Its clinical trials focus on evaluating its drug candidates, including Kevetrin for the treatment of cancers; Brilacidin, a potential therapeutic for the treatment of the novel coronavirus. The company... see more

GREY:CTIX - Post Discussion

Cellceutix > Question.
View:
Post by Seamusknows1972 on Apr 30, 2014 11:51am

Question.

Why no analyst coverage? Besides being on the OTC. Thanks in advance.
Comment by Johnnyola1 on May 03, 2014 11:17am
This post has been removed in accordance with Community Policy
Comment by Seamusknows1972 on May 04, 2014 11:17am
Thanks for your thoughts and info. I'm just trying to gather information beyond what you've suggested as well as other investor angles. It's just really hard to believe that this company with possibly three blockbusting drugs ... in reputable hospitals ... in trials has no real investors beyond who we speculate & insiders. Wouldn't smart money know to invest and push this onto ...more  
Comment by Johnnyola1 on May 09, 2014 5:54pm
This post has been removed in accordance with Community Policy
Comment by tennisman on Nov 03, 2015 4:15pm
stay the course, funding is there. there is a major shorter who has jerked ctix arounf. braciadin is getting ready to stary phase 3. So far the FDA has no negative remarks to prevent ctix to proceed.
Comment by rainman8945 on Nov 27, 2015 7:29pm
If there was any concerns by alpha. the lawyers have back off big time in their persuit of inproprieity
Comment by Johnnyola1 on May 09, 2014 5:59pm
This post has been removed in accordance with Community Policy
Comment by Johnnyola1 on May 09, 2014 6:06pm
This post has been removed in accordance with Community Policy
Cellceutix
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities